Michael H. Wholey, MD, MBA

Original Contribution

First Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension

01/15/2017

Mark Wholey , MD;

Emily Stein , PhD;

Venkateswara Rao , PhD;

Nicholas Kipshidze , MD, PhD;

Michael H. Wholey , MD, MBA;

Konstantin Kipiani , MD;

Horst Sievert , MD, FESC, FACC, FSCAI;

Vakhtang Kipiani , MD;

Tea Mukhuradze , MD;

An evaluation of the feasibility and safety of a novel targeted neuromodulatory treatment for sympathetic hypertension involving a one-time local injection of neurotropic agents near renal nerves.

An evaluation of the feasibility...

01/15/2017

Journal of Invasive Cardiology

Original Research

Percutaneous Closure of the Inadvertent Subclavian Artery Puncture During Central Venous Catheterization

09/05/2008

Michael H. Wholey , MD, MBA;

We report the use of an Angio-Seal™ Vascular Closure Device (St. Jude Medical, Minnetonka, MN) to close the arterial puncture site of the left subclavian artery (LSA) during inadvertent central line placement.

We report the use of an...

09/05/2008

Vascular Disease Management